Azenta, Inc. (AZTA)VA awarded $20K

$20K

committed so far

Signed

Apr 30, 2026

Updated

Jul 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 3, 2026CongressDisclosed purchase of AZTA — reported range $1,001 - $15,000
2. Mar 4, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
3. Apr 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 6, 2026, Ginger Zhou stepped down from her role as President of the Multiomics business of Azenta, Inc. (the “Company”). Dr. Zhou’s decision to step down was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
4. Apr 30, 2026 · this disclosureFederal contract · $20K obligatedDepartment of Veterans Affairs awarded Azenta, Inc.: $20K obligated to date

What came next

1. May 5, 2026Company filing · Form 8-K · ResultsReported its results
2. May 22, 2026Federal contract · $19K obligatedDepartment of Health and Human Services awarded Azenta, Inc.: $19K obligated to date
3. Jun 26, 2026Federal contract · $50K obligatedDepartment of Veterans Affairs awarded Azenta, Inc.: $50K obligated to date
4. Jul 1, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 1 more item)“On July 1, 2026, Azenta Germany GmbH, a wholly owned subsidiary of the Company, completed the sale of the entire issued share capital of B Medical Systems S.à r.l.”
5. Jul 28, 2026Federal contract · $5.5M obligatedDepartment of Health and Human Services awarded Azenta, Inc.: $5.54M obligated to date
6. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
7. Aug 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member
8. Aug 22, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 22, 2026, John P. Marotta resigned as President and Chief Executive Officer of Azenta, Inc. (the “Company”) and as a member of the Company’s Board of Directors (the “Board”), effective as of August 22, 2026 (the “Effective Date”).”
9. Aug 24, 2026Federal contract · $18K obligatedSmithsonian Institution awarded Azenta, Inc.: $18K obligated to date

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Azenta, Inc.

For Azenta, Inc., OQRO holds 5 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AZTA page.

How this filing works

• Contract ceiling vs obligated amount

Other disclosures at Azenta, Inc.

• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 28, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 10, 2026
• USAspending.gov award recordAug 25, 2026
• USAspending.gov award recordAug 25, 2026

Everything OQRO holds on this company is on its AZTA page.